| 產(chǎn)品編號 | 圖片 | CAS No. | 名稱及描述 | 規(guī)格 | 價(jià)格 | 分子式 | 快速訂購 |
|---|---|---|---|---|---|---|---|
| 200010-100MG |
|
2005443-99-0 |
(4R,?4'R)?-2,?2'-?環(huán)亞戊基雙[?4,?5-二氫-?4-?芐基惡唑] (4R,?4'R)?-2,?2'-?Cyclopentylidenebis[?4,?5-?dihydro-?4-?(phenylmethyl)?oxazole] 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C25H28N2O2 | |
| 135999-100MG |
|
444575-98-8 |
(4S,4'S)-2,2'-[2-苯基-1-(苯基甲基)亞乙基]雙[4-異丙基-4,5-二氫惡唑] (4S,4'S)-2,2'-[2-Phenyl-1-(phenylmethyl)ethylidene]bis[4-(1-methylethyl)-4,5-dihydrooxazole] 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C27H34N2O2 | |
| 136000-100MG |
|
880479-99-2 |
(4R,4'R)-2,2'-[2-苯基-1-(苯基甲基)亞乙基]雙[4-異丙基-4,5-二氫惡唑] (4R,4'R)-2,2'-[2-Phenyl-1-(phenylmethyl)ethylidene]bis[4-(1-methylethyl)-4,5-dihydrooxazole] 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C27H34N2O2 | |
| 135797-100MG |
|
175166-51-5 |
(3aS,3'aS,8aR,8'aR)-2,2'-異丙叉雙[3a,8a-二氫-8H-茚并[1,2-d]惡唑] (3aS,3'aS,8aR,8'aR)-2,2'-(1-Methylethylidene)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C23H22N2O2 | |
| 135798-100MG |
|
189623-45-8 |
(3aR,3'aR,8aS,8'aS)-2,2'-異丙叉雙[3a,8a-二氫-8H-茚并[1,2-d]惡唑] (3aR,3'aR,8aS,8'aS)-2,2'-(1-Methylethylidene)bis[3a,8a-dihydro-8H-indeno[1,2-d]oxazole] 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C23H22N2O2 | |
| 134862-100MG |
|
157825-96-2 |
(4S,4'S,5R,5'R)-2,2'-異丙叉雙[4,5-二氫-4,5-二苯基惡唑] (4S,4'S,5R,5'R)-2,2'-(1-Methylethylidene)bis[4,5-dihydro-4,5-diphenyloxazole] 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C33H30N2O2 | |
| 134863-100MG |
|
157904-67-1 |
(4R,4'R,5S,5'S)-2,2'-異丙叉雙[4,5-二氫-4,5-二苯基惡唑] (4R,4'R,5S,5'S)-2,2'-(1-Methylethylidene)bis[4,5-dihydro-4,5-diphenyloxazole] 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C33H30N2O2 | |
| 137112-100MG |
|
131833-93-7 |
(S,S)-2,2'-異丙叉雙(4-叔丁基-2-惡唑啉) 2,2-Bis[(4S)-4-tert-butyl-2-oxazolin-2-yl]propane 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C17H30N2O2 | |
| 137111-100MG |
|
131833-97-1 |
(R,R)-2,2'-異丙叉雙(4-叔丁基-2-惡唑啉) 2,2-Bis[(4R)-4-tert-butyl-2-oxazolin-2-yl]propane 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C17H30N2O2 | |
| 110396-100MG |
|
131833-92-6 |
(4S,4'S)-2,2'-異丙亞基雙(4-異丙基-2-惡唑啉) 2,2-Bis[(4S)-4-isopropyl-2-oxazolin-2-yl]propane 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C17H30N2O2 | |
| 110395-100MG |
|
150529-94-5 |
(4R,4'R)-2,2'-異丙亞基雙(4-異丙基-2-惡唑啉) 2,2-Bis[(4R)-4-isopropyl-2-oxazolin-2-yl]propane 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C15H26N2O2 | |
| 110386-100MG |
|
176706-98-2 |
(4S,4'S)-2,2'-異丙亞基雙(4-芐基-2-惡唑啉) 2,2-Bis[(4S)-4-benzyl-2-oxazolin-2-yl]propane 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C23H26N2O2 | |
| 110385-100MG |
|
141362-77-8 |
(4R,4'R)-2,2'-異丙亞基雙(4-芐基-2-惡唑啉) 2,2-Bis[(4R)-4-benzyl-2-oxazolin-2-yl]propane 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C23H26N2O2 | |
| 110376-100MG |
|
131457-46-0 |
(4S,4'S)-2,2'-異丙亞基雙(4-苯基-2-惡唑啉) 2,2-Bis[(4S)-4-phenyl-2-oxazolin-2-yl]propane 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C21H22N2O2 | |
| 110375-100MG |
|
150529-93-4 |
(4R,4'R)-2,2'-異丙亞基雙(4-苯基-2-噁唑啉) 2,2-Bis[(4R)-4-phenyl-2-oxazolin-2-yl]propane 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C21H22N2O2 | |
| 136085-100MG |
|
1037800-48-8 |
(S)?-4,?4',?6,?6'-?四三氟甲基-[1,?1'-?聯(lián)苯]?-?2,?2'-?二胺 (S)?-4,?4',?6,?6'-?Tetrakis(trifluorome?thyl)?-[1,?1'-?biphenyl]?-?2,?2'-?diamine 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C16H8F12N2 | |
| 136084-100MG |
|
1037800-51-3 |
(R)?-4,?4',?6,?6'-?四三氟甲基-[1,?1'-?聯(lián)苯]?-?2,?2'-?二胺 (R)?-4,?4',?6,?6'-?Tetrakis(trifluorome?thyl)?-[1,?1'-?biphenyl]?-?2,?2'-?diamine 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C16H8F12N2 | |
| 135054-100MG |
|
933782-32-2 |
N-[(S)- 2'-氨基[1,1'-聯(lián)萘]-2-基]-4-甲基苯亞磺酰胺 N-[(S)-2'-Amino-[1,1'-binaphthalen]-2-yl]-4-methylbenzenesulfonamide 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C27H22N2O2S | |
| 135055-100MG |
|
512170-32-0 |
N-[(R)- 2'-氨基[1,1'-聯(lián)萘]-2-基]-4-甲基苯亞磺酰胺 N-[(R)-2'-Amino-[1,1'-binaphthalen]-2-yl]-4-methylbenzenesulfonamide 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C27H22N2O2S | |
| 135053-100MG |
|
NA |
(S)-N-甲基-1,1'-聯(lián)萘胺 (S)-N-Methyl-[1,1'-binaphthalene]-2,2'-diamine 請咨詢 大賽璐 ≥98%,99%e.e. |
100MG | 需詢價(jià) | C21H18N2 | |
小泰
|
010-60710855
|